Estrogen replacement and risk of Alzheimer disease
Rosenberg, L.
JAMA 289(9): 1101; Author Reply 1101-2
2003
ISSN/ISBN: 0098-7484 PMID: 12622567 Document Number: 559057
Document emailed within 1 workday
Related Documents
Buckwalter, J.Galen.; Petitti, D.B.; Crooks, V.C. 2003: Estrogen replacement and risk of Alzheimer disease JAMA 289(9): 1101; Author Reply 1101-2Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Glaser, A.N. 2000: Estrogen-progestin replacement and risk of breast cancer JAMA 284(6): 692; Author Reply 693-4
Persson, I. 1996: Cancer risk in women receiving estrogen-progestin replacement therapy Maturitas 23(Suppl): S37-S45
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Trapido, E.J.; Brinton, L.A.; Schairer, C.; Hoover, R. 1984: Estrogen replacement therapy and benign breast disease Journal of the National Cancer Institute 73(5): 1101-1105
2002: New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use Lakartidningen 99(28-29): 3031-3034
Calle, E.E.; Miracle-McMahill, H.L.; Thun, M.J.; Heath, C.W. 1995: Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women Journal of the National Cancer Institute 87(7): 517-523
Doran, M.F.; Crowson, C.S.; O'Fallon, W.Michael.; Gabriel, S.E. 2004: The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study Journal of Rheumatology 31(2): 207-213
Slater, C.C.; Zhang, C.; Hodis, H.N.; Mack, W.J.; Boostanfar, R.; Shoupe, D.; Paulson, R.J.; Stanczyk, F.Z. 2001: Comparison of estrogen and androgen levels after oral estrogen replacement therapy Journal of Reproductive Medicine 46(12): 1052-1056
Nevitt, M.C.; Cummings, S.R.; Lane, N.E.; Hochberg, M.C.; Scott, J.C.; Pressman, A.R.; Genant, H.K.; Cauley, J.A. 1996: Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group Archives of Internal Medicine 156(18): 2073-2080
Dargent, D. 2000: Estrogen replacement therapy in patients in remission after treatment for estrogen dependent cancer. Certainties are still lacking Gynecologie Obstetrique and Fertilite 28(6): 427-428
Gindoff, P.R.; Stillman, R.J. 1994: Influence of cigarette smoking on age at menopause, estrogen-related disease, and hormone replacement therapy Lobo, R A Treatment of the postmenopausal woman: Basic and clinical aspects 295-300
Sitruk-Ware, R. 1990: Estrogen replacement therapy and cardiovascular disease in postmenopausal women. II. Mechanisms of action of estrogens Presse Medicale 19(29): 1364-1367
Barranco-Quintana, J.L.; Allam, M.F.; Del Castillo, A.S.; Navajas, R.F.-C. 2005: Risk factors for Alzheimer's disease Revista de Neurologia 40(10): 613-618
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Pfeffer, A.; Barcikowska, M. 1998: Non-smoking as risk factor for Alzheimer's disease? Neurologia i Neurochirurgia Polska 32(3): 515-521